Renal Function and All-Cause Mortality Risk Among Cancer Patients

被引:42
|
作者
Yang, Yan [1 ]
Li, Hui-yan [1 ]
Zhou, Qian [1 ]
Peng, Zhen-wei [2 ]
An, Xin [3 ]
Li, Wei [1 ]
Xiong, Li-ping [1 ]
Yu, Xue-qing [1 ]
Jiang, Wen-qi [3 ]
Mao, Hai-ping [1 ]
机构
[1] Sun Yat Sen Univ, Key Lab Nephrol, Minist Hlth China,Dept Nephrol, Guangdong Prov Key Lab Nephrol,Affiliated Hosp 1, 58 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Oncol, 58 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Ctr Canc, Dept Oncol, 651 Dongfeng Rd, Guangzhou 510080, Guangdong, Peoples R China
关键词
CHRONIC KIDNEY-DISEASE; COLORECTAL-CANCER; SURGICAL RESECTION; LUNG-CANCER; COMORBIDITY; INSUFFICIENCY; THERAPY; IMPACT; AGE; IMPAIRMENT;
D O I
10.1097/MD.0000000000003728
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Renal dysfunction predicts all-cause mortality in general population. However, the prevalence of renal insufficiency and its relationship with mortality in cancer patients are unclear. We retrospectively studied 9465 patients with newly diagnosed cancer from January 2010 to December 2010. Renal insufficiency was defined as an estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m(2) using the Chronic Kidney Disease Epidemiology Collaboration equation. The hazard ratio (HR) of all-cause mortality associated with baseline eGFR was assessed by Cox regression. Three thousand sixty-nine patients (32.4%) exhibited eGFR < 90 mL/min/1.73 m(2) and 3% had abnormal serum creatinine levels at the time of diagnosis. Over a median follow-up of 40.5 months, 2705 patients (28.6%) died. Compared with the reference group (eGFR >= 60 mL/min/1.73 m 2), an elevated all-cause mortality was observed among patients with eGFR< 60 mL/min/1.73 m(2) stratified by cancer stage in the entire cohort, the corresponding hazard ratios were 1.87 (95% CI, 1.41-2.47) and 1.28 (95% CI, 1.01-1.62) for stage I to III and stage IV, respectively. However, this relationship was not observed after multivariate adjustment. Subgroup analysis found that eGFR< 60 mL/min/1.73m 2 independently predicted death among patients with hematologic (adjusted HR 2.93, 95% CI [1.36-6.31]) and gynecological cancer (adjusted HR 2.82, 95% CI [1.19-6.70]), but not in those with other cancer. Five hundred fifty-seven patients (6%) had proteinuria. When controlled for potential confounding factors, proteinuria was a risk factor for all-cause mortality among patients in the entire cohort, regardless of cancer stage and eGFR values. When patients were categorized by specific cancer type, the risk of all-cause death was only significant in patients with digestive system cancer (adjusted HR, 1.85 [1.48-2.32]). The prevalence of renal dysfunction was common in patients with newly diagnosed cancer. Patients with eGFR < 60 mL/min/1.73 m(2) or proteinuria were associated with increased risk for all-cause mortality, this relation depended on cancer site.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Diastolic function as an early marker for systolic dysfunction and all-cause mortality among cancer patients
    Arnold, Joshua H.
    Rozenbaum, Zach
    Hochstadt, Aviram
    Rosen, Roni
    Sherez, Chen
    Sivan, Ayelet
    Mor, Liat
    Moshkovits, Yonatan
    Sadeh, Ben
    Havakuk, Ofer
    Milwidsky, Assi
    Shamai, Sivan
    Sirota Dorfman, Svetlana
    Arbel, Yaron
    Topilsky, Yan
    Laufer-Perl, Michal
    [J]. ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2021, 38 (04): : 540 - 548
  • [2] KIDNEY FUNCTION MEASURES AND THE RISK OF CANCER INCIDENCE, CANCER DEATH AND ALL-CAUSE MORTALITY
    Lees, Jennifer
    Ho, Frederick
    Parra-Soto, Solange
    Celis-Morales, Carlos
    Welsh, Paul
    Sullivan, Michael
    Jani, Bhautesh
    Sattar, Naveed
    Pell, Jill
    Webster, Angela
    Mark, Patrick
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 : 300 - 300
  • [3] DETERMINANTS OF ALL-CAUSE MORTALITY IN PATIENTS WITH METASTATIC PAPILLARY RENAL CELL CANCER
    Sidana, Abhinav
    Jain, Amit
    Kadakia, Meet
    Muthigi, Akhil
    Krane, Louis
    Ninos, Martha
    Friend, Julia
    Shih, Johanna
    Srinivasan, Ramaprasad
    [J]. JOURNAL OF UROLOGY, 2017, 197 (04): : E62 - E62
  • [4] Risk of All-Cause Mortality, Cardiovascular Disease Mortality, and Cancer Mortality in Patients With Bullous Pemphigoid
    Shen, Wan-Chieh
    Chiang, Hsiu-Yin
    Chen, Pei-Shan
    Lin, Yu-Ting
    Kuo, Chin-Chi
    Wu, Po-Yuan
    [J]. JAMA DERMATOLOGY, 2022, 158 (02) : 167 - 175
  • [5] In-hospital renal function variability and all-cause mortality among patients hospitalized for acute heart failure
    Chun, K. H. Kyeong-Hyeon
    Oh, J.
    Lee, C. J.
    Kang, S. M.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 98 - 99
  • [7] Renal function and metabolic syndrome components on cardiovascular and all-cause mortality
    Chien, Kuo-Liong
    Hsu, Hsiu-Ching
    Lee, Yuan-Teh
    Chen, Ming-Fong
    [J]. ATHEROSCLEROSIS, 2008, 197 (02) : 860 - 867
  • [8] Significantly increased risk of all-cause mortality among cardiac patients feeling lonely
    Christensen, Anne Vinggaard
    Juel, Knud
    Ekholm, Ola
    Thrysoe, Lars
    Thorup, Charlotte Brun
    Borregaard, Britt
    Mols, Rikke Elmose
    Rasmussen, Trine Bernholdt
    Berg, Selina Kikkenborg
    [J]. HEART, 2020, 106 (02) : 140 - 146
  • [9] Risk of Secondary Cardiovascular Disease and All-Cause Mortality among Patients with and without Diabetes
    Nichols, Gregory A.
    Pedula, Kathryn L.
    Wang, Fang
    Bell, Timothy J.
    [J]. DIABETES, 2009, 58 : A27 - A27
  • [10] RISK FACTORS FOR ALL-CAUSE MORTALITY AFTER SUCCESSFUL RENAL TRANSPLANTATION
    Vanrenterghem, Yves
    Villa, M.
    Fieuws, S.
    Montagnino, G.
    Maes, B.
    Ponticelli, C.
    [J]. NEPHROLOGY, 2005, 10 : A325 - A325